Illumina Acquires Fluent BioSciences to Accelerate Single-cell Analysis and Discovery


Gary Zweiger, Ph.D.

Founder, Adviser

Gary brings to Fluent BioSciences his vast business-development experience in DNA sequencing and other genomics technologies (such as microarrays, PCR, imaging, and more). He gained that experience working at Affymetrix, Life Technologies, and Agilent. Now, as an investor-entrepreneur, Gary helps startups evaluate markets, gauge partnering opportunities, and weigh investor interest in areas that include liquid biopsy assays and tools, sequencing, sample prep, genome editing, and therapeutics.

He received a BS and PhD from Stanford University School of Medicine’s Genetics Department.